Serum markers in pre-eclampsia

Biomarkers

Volumn 14, Issue 6, 2009, Pages 395-400

  Kharb, Simmi ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Haemostatic parameters; Oxidative stress; Prreclampsia; Serum markers; VEGF

Indexed keywords

3 NITROTYROSINE; ACTIVIN A; ANTIBODY; ANTIOXIDANT; ANTITHROMBIN III; CALCIUM; CHORIONIC GONADOTROPIN; COMPLEMENT COMPONENT C1S INHIBITOR; DNA; FIBRONECTIN; HAPTOGLOBIN; HEAT SHOCK PROTEIN; HEMOGLOBIN; HOMOCYSTEINE; IRON; LIPID; LOW DENSITY LIPOPROTEIN; MARKER; PLASMINOGEN ACTIVATOR INHIBITOR; TUMOR NECROSIS FACTOR; URIC ACID; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VITAMIN D;

BIOCHEMISTRY; CIRCULATION; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ERYTHROCYTE STRUCTURE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; LIPID PEROXIDATION; LIVER FUNCTION TEST; MATERNAL HYPERTENSION; NEWBORN MORBIDITY; NEWBORN MORTALITY; OXIDATIVE STRESS; PATHOGENESIS; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PROTEINURIA; REVIEW; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERTENSION; LABORATORY TECHNIQUES AND PROCEDURES; PRE-ECLAMPSIA; PREGNANCY;

EID: 70849128760     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500903033415     Document Type: Review

References (56)

1. Armstong VW, Wieland E, Diedrich F. (1994). Serum antibodies to oxidized low-density lipoprotein in preeclampsia and coronary heart disease. Lancet 343:1570.
2. August P, Marcaccio B, Gertner JM, Druzin MI, Resnick LM, Laragh JH. (1992). Abnormal 1, 25-dihydroxy vitamin D metabolism in preeclampsia. Am J Obstet Gynecol 166:1295-1299
3. Ayhan A, Akkok E, Urman B. (1990). Beta thromboglobulin and platelet factor levels in pregnancy and preeclampsia. Gynecol Obstet Invest 30:12-14.
4. Ballegeer V, Spitiz B, Kiechens L. (1989). Predictive value of increased levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 161:432-436
5. Benyo DF, Miles TM, Conrad KP. (1997). Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 82:1582-1588
6. Branch DW, Mitchell MD, Miller E, Palinski W, Witzum JL. (1994). Preeclampsia and serum antibodies to oxidized low-density lipoprotein. Lancet 343:645-646
7. Burrow RF, Hunter DJ, Andrew M. (1987). A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol 70:334-338
8. Burrows RF, Kelton JG. (1990). Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 162:731-734
9. Butterworth BH, Green IA, Liston WA, Haddad NG, Johnson TA. (1999). Immunocytochemical localization of neutrophil elastase in term placenta deciduas and myometrium in pregnancy- induced hypertension. Br J Obstet Gynecol 98:929-933
10. Cadroy Y, Grandjean H, Pichon J. (1993). Evaluation of six markers of hemostatic system in normal and pregnancy complicated by hypertension or preeclampsia, Br J Obstet Gynaecol 100:461-465
11. Chesley LC. (1985). Diagnosis of preeclampsia. Am J Obstet Gynecol 65:423-425
12. Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF. (2008). The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Med, 21:25-40.
13. Cunningham FG, Lowe T, Guss S. (1985). Erythrocyte morphology in women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 153:358-362
14. Davidge ST, Hubel CA, Brayden RD, Capeless EC, McLaughlin MK. (1992). Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 79:897-901.
15. Del Valle GO, Wolf BC, Baker CA. (2000). Free alpha-hCG: a potential marker for severe preeclampsia. J Matern Fetal Invest 3:137-140
16. Diesch CH, Holzgreve W, Hahn S, Zhong XY. (2006). Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenat Diagn 26:1267-1270
17. Elias AN, Vaziri MD, Pandian MR. (1988). Atrial natriuretic peptide and arginine vasopressin in pregnancy and pregnancy-induced hypertension. Nephron 49:140-143
18. Entman SS, Richardson LD, Moore RM. (1982). Elevated serum iron in toxemia of pregnancy. Am J Obstet Gynecol 143:398-404.
19. Fay RA, Bowman DR, Brooks JA. (1985). Platelets and uric acid in prediction of preeclampsia. Am J Obstet Gynecol 152:1038-1039
20. Hahn S, Holzgreve W. (2002). Fetal cells and cell-free fetal DNA in maternal blood:new insights into preeclampsia Hum Reprod Update 8:501-508
21. Higgins JR, Papayianni A, Brady HR, Michael RN, Darling MD, Joseph JW. (1998). Circulating vascular cell adhesion molecule- 1 in preeclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in preeclampsia. Am J Obstet Gynecol 179:464-469
22. Hubel CA, Roberts JM, Taylor RN. (1989). Lipid peroxidation in preeclampsia: new perspectives on pre-eclampsia. Am J Obstet Gynecol 161:1025-1034
23. Hubel CA. (1998). Dyslipidemia, iron, and oxidative stress in preeclampsia:Assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 16:75-92.
24. Huikeshoven FJ, Zuijderhoudt FM. (1990). Hypocalciuria in hypertensive disorder in pregnancy and how to measure it. Eur J Obstet Gynecol Reprod Biol 36:81-85
25. Inglis TCM, Stuart J, George AJ. (1982). Haemostatic and rheological changes in normal pregnancy and preeclampsia. Br J Haematol 50:461-465
26. Kaaja R. (1998). Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 16:41-46
27. Kharb S. (2000a). Vitamin E and C in preeclampsia. Eur J Obstet Gynecol 93:37-39
28. Kharb S. (2000b). Total free radical trapping antioxidant potential in preeclampsia. Int J Gynecol Obstet 69:23-26
29. Kharb S. (2000c). Lipid peroxidation in pregnancy with preeclampsia and diabetes. Gynecol Obstet Invest 50:113-116
30. Kharb S, Gulati N, Singh V, Singh GP. (1998). Lipid peroxidation and vitamin E levels in preeclampsia. Gynecol Obstet Invest 46:238-240
31. Kharb S, Singh GP. (2001). Hyperuricemia, oxidative stress in preeclampsia. Clin Chim Acta 305:201-203
32. Kitzmiller JL, Lang JE, Yelenosky PF. (1973). Hematologic assays in preeclampsia. Am J Obstet Gynecol 11:362-367
33. Kurki T, Ailus K, Palosuo T, Ylikorkala O. (1996). Oxidized low density lipoprotein cardiolipin and phosphatidylserine fail to predict the risk of preeclampsia. Hypertens Pregn 15:251-256
34. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. (2004). Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683
35. Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V. (2005). Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int J Gynaecol Obstet 89:251-257
36. Molvarec A, Prohaszka Z, Nagy B, Szalay J, Fust G, Karadi I, Rigo J. (2006). Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. J Hum Hyperten 20:780-786
37. Molvarec A, Prohaszka Z, Nagy B, Kalabay L, Szalay J, Fust G, Karadi I, Rigo J. (2007). Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. J Reprod Immunol 73:172-179
38. Molvarec A, Rigo J Jr, Lazar L, Balogh K, Mako V, Cervenak L, Mezes M, Prohaszka Z. (2009). Increased serum heat shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 14:151-159
39. Powers RW, Evans RW, Majors AK. (1998). Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 179:1605-1611
40. Redman CW, Denson KW, Beilin LJ. (1977). Factor VIII consumption in preeclampsia, Lancet 1:1249-1252
41. Redman CW, Boonar J, Beilin LJ. (1975). Prolactin in hypertensive pregnancies. BMJ 1:304-306
42. Reith A, Booth NA, Moore NR. (1993). Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, preeclampsia and hydatiform mole. Br J Obstet Gynaecol 100:370-374
43. Roggensack A, Zhang Y, Davidge S. (1999). Evidence for peroxyintrite formation in the vasculature of women with preeclampsia. Hypertension 33:83-89
44. Sibai BM. (1988). Pit falls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 159:1-5.
45. Steinberg G, Khankin EV, Karumanchi SA. (2009). Angiogenic factors and preeclampsia. Thromb Res 123 (Suppl. 2):S93-9.
46. Stepan H. (2009). Angiogenic factors and pre-eclampsia: an early marker is needed. Clin Sci (London) 116:231-232
47. Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. (1998). Antibodies against copper - oxidized and malondialdehyde - modified low-density lipoproteins in preeclamptic pregnancies. Br J Obstet Gynaecol 105:1113-1117
48. Uotila JT, Tuimala KJ, Aarnio JM. (1993). Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynaecol 100:270-276
49. Varma TR. (1992). Serum uric acid levels as an index of fetal prognosis in pregnancies complicated by preexisting hypertension and preeclampsia of pregnancy. Int J Gynecol Obstet 92:401-408
50. Walsch SC. (1994). Lipid peroxidation in pregnancy. Hypertens Pregn 13:1-25.
51. Wataganara T, Bianchi DW. (2004). Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann NY Acad Sci 1022:90-99
52. Weiner CP, Brandt J. (1982). Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia/eclampsia. Am J Obstet Gynecol 142:275-281
53. Weinstein L. (1985). Preeclampsia/eclampsia with hemolysis elevated liver enzymes, and thrombocytopenia Obstet Gynecol 66:657-670
54. Weinstein L. (1982). Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142:159-167
55. Wisdom SJ, Wilson R, McKillop JH, Walker JJ. (1991). Antioxidant system in normal pregnancy and in pregnancy - induced hypertension. Am J Obstet Gynecol 165:1701-1704
56. Zhong XY, Holzgreve W, Hahn S. (2002). The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregn 21:77-83.